Molecular Imaging of Induced Pluripotent Stem Cell Immunogenicity with In Vivo Development in Ischemic Myocardium

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Liu, Zhiqiang ^a   Wen, Xinyu ^b   Wang, Haibin ^a   Zhou, Jin ^a   Zhao, Mengge ^a,d   Lin, Qiuxia ^a   Wang, Yan ^a   Li, Junjie ^a   Li, Dexue ^a   Du, Zhiyan ^a   Yao, Anning ^a   Cao, Feng ^c   Wang, Changyong ^a  

^a BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^b CHINESE PLA GENERAL HOSPITAL   (China)

^c FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^d Michigan State University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; FIREFLY LUCIFERASE; RED FLUORESCENT PROTEIN; THYMIDINE KINASE;

ACUTE GRAFT REJECTION; ALLOGENEIC STEM CELL TRANSPLANTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOLUMINESCENT IMAGING; CELL DIFFERENTIATION; CELL INFILTRATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; FEMALE; HEART INFARCTION; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; IMMUNE DEFICIENCY; IMMUNOCOMPETENT CELL; IMMUNOGENICITY; IN VIVO STUDY; MOLECULAR IMAGING; MOUSE; NONHUMAN; PLURIPOTENT STEM CELL; REPORTER GENE; TERATOMA;

ANIMALS; CELL DEATH; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CELL TRACKING; FEMALE; GENES, REPORTER; GRAFT REJECTION; INDUCED PLURIPOTENT STEM CELLS; MICE; MICE, 129 STRAIN; MICE, INBRED C57BL; MYOCARDIAL INFARCTION; MYOCARDIUM; MYOCYTES, CARDIAC; TERATOMA; TRANSDUCTION, GENETIC; WHOLE BODY IMAGING;

IPS; MURINAE;

EID: 84879271029     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0066369     Document Type: Article

References (37)

1. Miyahara Y, Nagaya N, Kataoka M, Yanagawa B, Tanaka K, et al. (2006) Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction. Nat Med 12: 459-465.
2. Qiao H, Zhang H, Zheng Y, Ponde DE, Shen D, et al. (2009) Embryonic stem cell grafting in normal and infarcted myocardium: serial assessment with MR imaging and PET dual detection. Radiology 250: 821-829.
3. Mummery C, Ward-van Oostwaard D, Doevendans P, Spijker R, van den Brink S, et al. (2003) Differentiation of human embryonic stem cells to cardiomyocytes: role of coculture with visceral endoderm-like cells. Circulation 107: 2733-2740.
4. Xu C, Police S, Rao N, Carpenter MK, (2002) Characterization and enrichment of cardiomyocytes derived from human embryonic stem cells. Circ Res 91: 501-508.
5. Kehat I, Kenyagin-Karsenti D, Snir M, Segev H, Amit M, et al. (2001) Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J Clin Invest 108: 407-414.
6. Passier R, van Laake LW, Mummery CL, (2008) Stem-cell-based therapy and lessons from the heart. Nature 453: 322-329.
7. Takahashi K, Yamanaka S, (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126: 663-676.
8. Lowry WE, Richter L, Yachechko R, Pyle AD, Tchieu J, et al. (2008) Generation of human induced pluripotent stem cells from dermal fibroblasts. Proc Natl Acad Sci U S A 105: 2883-2888.
9. Asgari S, Pournasr B, Salekdeh GH, Ghodsizadeh A, Ott M, et al. (2010) Induced pluripotent stem cells: a new era for hepatology. J Hepatol 53: 738-751.
10. Wernig M, Zhao JP, Pruszak J, Hedlund E, Fu D, et al. (2008) Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease. Proc Natl Acad Sci U S A 105: 5856-5861.
11. Hanna J, Wernig M, Markoulaki S, Sun CW, Meissner A, et al. (2007) Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science 318: 1920-1923.
12. Nelson TJ, Martinez-Fernandez A, Yamada S, Perez-Terzic C, Ikeda Y, et al. (2009) Repair of acute myocardial infarction by human stemness factors induced pluripotent stem cells. Circulation 120: 408-416.
13. Zhao T, Zhang ZN, Rong Z, Xu Y, (2011) Immunogenicity of induced pluripotent stem cells. Nature 474: 212-215.
14. Hofmann M, Wollert KC, Meyer GP, Menke A, Arseniev L, et al. (2005) Monitoring of bone marrow cell homing into the infarcted human myocardium. Circulation 111: 2198-2202.
15. Bulte JW, Kraitchman DL, (2004) Iron oxide MR contrast agents for molecular and cellular imaging. NMR Biomed 17: 484-499.
16. Terrovitis J, Lautamaki R, Bonios M, Fox J, Engles JM, et al. (2009) Noninvasive quantification and optimization of acute cell retention by in vivo positron emission tomography after intramyocardial cardiac-derived stem cell delivery. J Am Coll Cardiol 54: 1619-1626.
17. Cao F, Lin S, Xie X, Ray P, Patel M, et al. (2006) In vivo visualization of embryonic stem cell survival, proliferation, and migration after cardiac delivery. Circulation 113: 1005-1014.
18. Love Z, Wang F, Dennis J, Awadallah A, Salem N, et al. (2007) Imaging of mesenchymal stem cell transplant by bioluminescence and PET. J Nucl Med 48: 2011-2020.
19. Zhou R, Acton PD, Ferrari VA, (2006) Imaging stem cells implanted in infarcted myocardium. J Am Coll Cardiol 48: 2094-2106.
20. Li Z, Lee A, Huang M, Chun H, Chung J, et al. (2009) Imaging survival and function of transplanted cardiac resident stem cells. J Am Coll Cardiol 53: 1229-1240.
21. Cao N, Liu Z, Chen Z, Wang J, Chen T, et al. (2012) Ascorbic acid enhances the cardiac differentiation of induced pluripotent stem cells through promoting the proliferation of cardiac progenitor cells. Cell Res 22: 219-236.
22. Crescini E, Gualandi L, Uberti D, Prandelli C, Presta M, et al. (2013) Ascorbic acid rescues cardiomyocyte development in Fgfr1(-/-) murine embryonic stem cells. Biochim Biophys Acta 1833: 140-147.
23. Ou DB, Zeng D, Jin Y, Liu XT, Teng JW, et al. (2013) The long-term differentiation of embryonic stem cells into cardiomyocytes: an indirect co-culture model. PLoS ONE 8: e55233.
24. Klug MG, Soonpaa MH, Koh GY, Field LJ, (1996) Genetically selected cardiomyocytes from differentiating embronic stem cells form stable intracardiac grafts. J Clin Invest 98: 216-224.
25. Liu S, Qu Y, Stewart TJ, Howard MJ, Chakrabortty S, et al. (2000) Embryonic stem cells differentiate into oligodendrocytes and myelinate in culture and after spinal cord transplantation. Proc Natl Acad Sci U S A 97: 6126-6131.
26. Asano T, Ageyama N, Takeuchi K, Momoeda M, Kitano Y, et al. (2003) Engraftment and tumor formation after allogeneic in utero transplantation of primate embryonic stem cells. Transplantation 76: 1061-1067.
27. Kolossov E, Bostani T, Roell W, Breitbach M, Pillekamp F, et al. (2006) Engraftment of engineered ES cell-derived cardiomyocytes but not BM cells restores contractile function to the infarcted myocardium. J Exp Med 203: 2315-2327.
28. Caspi O, Huber I, Kehat I, Habib M, Arbel G, et al. (2007) Transplantation of human embryonic stem cell-derived cardiomyocytes improves myocardial performance in infarcted rat hearts. J Am Coll Cardiol 50: 1884-1893.
29. Smith AJ, Nelson NG, Oommen S, Hartjes KA, Folmes CD, et al. (2012) Apoptotic susceptibility to DNA damage of pluripotent stem cells facilitates pharmacologic purging of teratoma risk. Stem Cells Transl Med 1: 709-718.
30. Vazquez-Martin A, Cufi S, Lopez-Bonet E, Corominas-Faja B, Oliveras-Ferraros C, et al. (2012) Metformin limits the tumourigenicity of iPS cells without affecting their pluripotency. Sci Rep 2: 964.
31. Uosaki H, Fukushima H, Takeuchi A, Matsuoka S, Nakatsuji N, et al. (2011) Efficient and Scalable Purification of Cardiomyocytes from Human Embryonic and Induced Pluripotent Stem Cells by VCAM1 Surface Expression. PLoS ONE 6: e23657.
32. Chan SS, Li HJ, Hsueh YC, Lee DS, Chen JH, et al. (2010) Fibroblast growth factor-10 promotes cardiomyocyte differentiation from embryonic and induced pluripotent stem cells. PLoS ONE 5: e14414.
33. Kattman SJ, Witty AD, Gagliardi M, Dubois NC, Niapour M, et al. (2011) Stage-specific optimization of activin/nodal and BMP signaling promotes cardiac differentiation of mouse and human pluripotent stem cell lines. Cell Stem Cell 8: 228-240.
34. Huang J, Chen T, Liu X, Jiang J, Li J, et al. (2009) More synergetic cooperation of Yamanaka factors in induced pluripotent stem cells than in embryonic stem cells. Cell Res 19: 1127-1138.
35. Willmann JK, Paulmurugan R, Rodriguez-Porcel M, Stein W, Brinton TJ, et al. (2009) Imaging gene expression in human mesenchymal stem cells: from small to large animals. Radiology 252: 117-127.
36. Liu Z, Wang H, Wang Y, Lin Q, Yao A, et al. (2012) The influence of chitosan hydrogel on stem cell engraftment, survival and homing in the ischemic myocardial microenvironment. Biomaterials 33: 3093-3106.
37. Swijnenburg RJ, Tanaka M, Vogel H, Baker J, Kofidis T, et al. (2005) Embryonic stem cell immunogenicity increases upon differentiation after transplantation into ischemic myocardium. Circulation 112: I166-172.